Structural basis for selective inhibition of human GABA transporter GAT3
Open accessPreprint — published as 10.1038/s41467-026-68479-0 · Paper page
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
The astrocytic γ-aminobutyric acid (GABA) transporter, GAT3, is essential for terminating GABAergic signalling in the central nervous system. Selective inhibition of GAT3 offers a potential strategy for elevating extracellular GABA levels for the treatment of neurological disorders including epilepsy. However, few potent and selective GAT3 inhibitors have been developed, and their mechanisms of inhibition remain poorly understood. Here, we present the cryo-electron microscopy structures of full-length, wild-type human GAT3 bound to a selective inhibitor, to substrate GABA, or in substrate-free state. GAT3 bound to the inhibitor or in the substrate-free state exhibits an inward-open conformation. The inhibitor binds within the intracellular permeation pathway, positioned between transmembrane helices 1, 2, 3, 6, 7, and 8. The GABA-bound GAT3 is captured in an inward-occluded state, revealing the ion coordination and substrate recognition network, including a cation-π interaction between GABA’s γ-amino group and a phenylalanine residue in transmembrane helix 6. Our data reveal the molecular determinants for the inhibitor selectivity, and the mode of substrate binding and transport inhibition, providing blueprints for the rational design of next-generation selective GAT3 inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 SR-THAP is a selective non-competitive inhibitor of hGAT3. a SR-THAP inhibits [3H]GABA uptake by hGAT3 expressed in HEK293T cells with an IC50 of 25.2 [21.8; 30.4] μM without preincubation (blue) and 4.4 [3.6; 5.2] µM, 4.5 [3.4; 5.9] µM, and 4.9 [3.3; 7.0] μM after 15, 30, and 120 min preincubation, respectively. b The enantiomer RS-THAP inhibits [3H]GABA uptake by hGAT3 expressed in HEK293T cells, but with significantly reduced potency, with estimated IC50 values of >600 μM without preincubation and >100 μM with preincubation. c [3H]GABA uptake by hGAT3 can also be inhibited by non-radioactive GABA, although showing minimal shift in potency after 120 min preincubation, with IC50 values of 8.5 [6.4; 11] and 5.4 [4.6; 6.4] μM, respectively. d [3H]GABA uptake kinetic experiment fitted to the Michaelis–Menten model, performed with increasing concentrations of SR-THAP without preincubation (left) or after 120 min of preincubation (middle), before addition of [3H]GABA. Right panel shows the Michaelis–Menten kinetic parameters derived from the graphs in the left and middle panels, without (top) and with (bottom) 120 min preincubation. Statistical differences from control were determined by a two-sided F test and are indicated with stars as: * - P ≤ 0.05, ** - P ≤ 0.01. For reference, the F-test p values were 0.029 (0.5 µM), 0.0021 (2 µM), and 0.0015 (10 µM) without preincubation, and 0.652 (0.5 µM) and 0.0022 (2 µM) with preincubation. Data points are shown as individual replicates from n = 3 biological replicates (triplicate measurements) unless otherwise stated. Source data are provided as a Source data file.](https://figures.cochat.ai/paper-figures/5b212a5321fc4652a55dd77ce6483343/structural-basis-for-selective-inhibition-of-human-gaba-transporter-gat3-figure-1.jpg)

![Fig. 3 Inhibitor SR-THAP and substrate GABA bind to the central binding pocket of hGAT3. a Overall structure of the human GAT3 bound to the selective inhibitor SR-THAP (orange sticks) and cryo-EM density of SR-THAP (map contour level = 0.072 in ChimeraX). b Zoomed-in view of the binding mode of SR-THAP (orange) of hGAT3. Protein backbone is shown as ribbons (azure) and chloride ion as green sphere. Interacting residues within 3 Å of the inhibitor are displayed. To better illustrate the compound’s protonation state and its interactions with hGAT3, the polar hydrogens are shown even though they are not resolved at this resolution. H-bonds and cation-π interactions are displayed with yellow and green dashed lines, respectively. c The hGAT3-E66Y mutant shows a near-complete loss of [3H]GABA uptake, with only ~5% transport activity remaining compared to wild-type hGAT3, while hGAT3-C316S retains approximately 60% transport activity. Data points are individual measurements from either two biological replicates (hGAT3-E66Y) or three biological replicates (hGAT3-wt and hGAT3-C316S), each biological replicate was measured in triplicates. Error bars for hGAT3-wt and hGAT3-C316S represent SEM, and for hGAT3-E66Y, they represent SD. d [3H]GABA uptake inhibition by non-radioactive GABA is not affected in the hGAT3-C316S mutant compared to the wild-type hGAT3 with an IC50 value of 4.2 [2.3; 7.9] μM. e [3H]GABA inhibition by SR-THAP is affected by the C316S mutation with a reduced potency of 10.6 [8.6; 12.7] μM, compared to 4.9 [3.3; 7.0] μM for the wild-type hGAT3. Both experiments were performed with 120 min preincubation. Data points are shown as individual replicates from n = 3 biological replicates (triplicate measurements) unless otherwise stated. f Overall structure of the hGAT3 bound to its substrate GABA (blue sticks) and cryo-EM density map of GABA (map contour level = 0.06 in ChimeraX). g Zoomed-in view of the binding mode of GABA (blue) at hGAT3. Protein backbone is shown as ribbons (green), chloride ion as a green sphere, sodium ion as a red sphere, and the same residues from (b) as sticks. Source data are provided as a Source data file.](https://figures.cochat.ai/paper-figures/10c1227042a44a7781d35cb663b06586/structural-basis-for-selective-inhibition-of-human-gaba-transporter-gat3-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
UCSF ChimeraX: Structure visualization for researchers, educators, and developers
Pettersen, E. F., Goddard, T. D., Huang, C. C., Meng, E. C., Couch, G. S., Croll, T. I., Morris, J. H., & Ferrin, T. E. (2021) · Protein Science · doi:10.1002/pro.3943 · Cited by 9,514
Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051256o · Cited by 6,851
Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9644-8 · Cited by 6,006
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081
Croll, T. I. (2018) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798318002425 · Cited by 2,038
Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction
Punjani, A., Zhang, H., & Fleet, D. J. (2020) · Nature Methods · doi:10.1038/s41592-020-00990-8 · Cited by 1,683
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
Yamashita, A., Singh, S. K., Kawate, T., Jin, Y., & Gouaux, E. (2005) · Nature · doi:10.1038/nature03978 · Cited by 1,661
Simple Allosteric Model for Membrane Pumps
JARDETZKY, O. (1966) · Nature · doi:10.1038/211969a0 · Cited by 1,291
Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke
Clarkson, A. N., Huang, B. S., MacIsaac, S. E., Mody, I., & Carmichael, S. T. (2010) · Nature · doi:10.1038/nature09511 · Cited by 869
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
X-ray structures and mechanism of the human serotonin transporter
Coleman, J. A., Green, E. M., & Gouaux, E. (2016) · Nature · doi:10.1038/nature17629 · Cited by 668
X-ray structure of dopamine transporter elucidates antidepressant mechanism
Penmatsa, A., Wang, K. H., & Gouaux, E. (2013) · Nature · doi:10.1038/nature12533 · Cited by 612
GABA TRANSPORTER HETEROGENEITY: PHARMACOLOGY AND CELLULAR LOCALIZATION
BORDEN, L. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00158-1 · Cited by 589
Jung, M. J., Lippert, B., Metcalf, B. W., Böhlen, P., & Schechter, P. J. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10721.x · Cited by 480
Neurotransmitter and psychostimulant recognition by the dopamine transporter
Wang, K. H., Penmatsa, A., & Gouaux, E. (2015) · Nature · doi:10.1038/nature14431 · Cited by 425
Kidmose, R. T., Juhl, J., Nissen, P., Boesen, T., Karlsen, J. L., & Pedersen, B. P. (2019) · IUCrJ · doi:10.1107/s2052252519007619 · Cited by 385
Conti, F., Minelli, A., & Melone, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.03.003 · Cited by 353
GABA and Glutamate Transporters in Brain
Zhou, Y., & Danbolt, N. C. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00165 · Cited by 343
Wu, Z., Guo, Z., Gearing, M., & Chen, G. (2014) · Nature Communications · doi:10.1038/ncomms5159 · Cited by 306
Serotonin transporter–ibogaine complexes illuminate mechanisms of inhibition and transport
Coleman, J. A., Yang, D., Zhao, Z., Wen, P.-C., Yoshioka, C., Tajkhorshid, E., & Gouaux, E. (2019) · Nature · doi:10.1038/s41586-019-1135-1 · Cited by 268
Astrocytic GABA transporter activity modulates excitatory neurotransmission
Boddum, K., Jensen, T. P., Magloire, V., Kristiansen, U., Rusakov, D. A., Pavlov, I., & Walker, M. C. (2016) · Nature Communications · doi:10.1038/ncomms13572 · Cited by 222
A mechanism for intracellular release of Na+ by neurotransmitter/sodium symporters
Malinauskaite, L., Quick, M., Reinhard, L., Lyons, J. A., Yano, H., Javitch, J. A., & Nissen, P. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2894 · Cited by 181
Astrocytes convert network excitation to tonic inhibition of neurons
Héja, L., Nyitrai, G., Kékesi, O., Dobolyi, Á., Szabó, P., Fiáth, R., Ulbert, I., Pál-Szenthe, B., Palkovits, M., & Kardos, J. (2012) · BMC Biology · doi:10.1186/1741-7007-10-26 · Cited by 174
GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors
Dalby, N. O. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00075-7 · Cited by 157
Illumination of serotonin transporter mechanism and role of the allosteric site
Yang, D., & Gouaux, E. (2021) · Science Advances · doi:10.1126/sciadv.abl3857 · Cited by 149
Guo, H., Franken, E., Deng, Y., Benlekbir, S., Singla Lezcano, G., Janssen, B., Yu, L., Ripstein, Z. A., Tan, Y. Z., & Rubinstein, J. L. (2020) · IUCrJ · doi:10.1107/s205225252000929x · Cited by 143
Kersanté, F., Rowley, S. C. S., Pavlov, I., Gutièrrez‐Mecinas, M., Semyanov, A., Reul, J. M. H. M., Walker, M. C., & Linthorst, A. C. E. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.246298 · Cited by 142
Adkins, J. C., & Noble, S. (1998) · Drugs · doi:10.2165/00003495-199855030-00013 · Cited by 131
GABA uptake-dependent Ca 2+ signaling in developing olfactory bulb astrocytes
Doengi, M., Hirnet, D., Coulon, P., Pape, H.-C., Deitmer, J. W., & Lohr, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809513106 · Cited by 125
Structural basis of GABA reuptake inhibition
Motiwala, Z., Aduri, N. G., Shaye, H., Han, G. W., Lam, J. H., Katritch, V., Cherezov, V., & Gati, C. (2022) · Nature · doi:10.1038/s41586-022-04814-x · Cited by 123
Structure-based discovery of conformationally selective inhibitors of the serotonin transporter
Singh, I., Seth, A., Billesbølle, C. B., Bráz, J. M., Rodriguiz, R. M., Roy, K., Bekele, B., Craik, V., Huang, X., Boytsov, D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.04.010 · Cited by 106
Dopamine reuptake and inhibitory mechanisms in human dopamine transporter
Li, Y., Wang, X., Meng, Y., Hu, T., Zhao, J., Li, R., Bai, Q., Yuan, P., Han, J. H., Hao, K., et al. (2024) · Nature · doi:10.1038/s41586-024-07796-0 · Cited by 105
Structural insights into the inhibition of glycine reuptake
Shahsavar, A., Stohler, P., Bourenkov, G., Zimmermann, I., Siegrist, M., Guba, W., Pinard, E., Sinning, S., Seeger, M. A., Schneider, T. R., et al. (2021) · Nature · doi:10.1038/s41586-021-03274-z · Cited by 101
Self-citationMolecular basis for substrate recognition and transport of human GABA transporter GAT1
Zhu, A., Huang, J., Kong, F., Tan, J., Lei, J., Yuan, Y., & Yan, C. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-00983-z · Cited by 76
White, H. S., Sarup, A., Bolvig, T., Kristensen, A. S., Petersen, G., Nelson, N., Pickering, D. S., Larsson, O. M., Frølund, B., Krogsgaard‐Larsen, P., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034819 · Cited by 72
Self-citationStructure of the human dopamine transporter in complex with cocaine
Nielsen, J. C., Salomon, K., Kalenderoglou, I. E., Bargmeyer, S., Pape, T., Shahsavar, A., & Loland, C. J. (2024) · Nature · doi:10.1038/s41586-024-07804-3 · Cited by 67
Self-citationTransport mechanism and pharmacology of the human GlyT1
Wei, Y., Li, R., Meng, Y., Hu, T., Zhao, J. L., Gao, Y., Bai, Q., Li, N., & Zhao, Y. (2024) · Cell · doi:10.1016/j.cell.2024.02.026 · Cited by 63
Kanner, B. I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210525200 · Cited by 61
Astrocytes regulate inhibitory neurotransmission through GABA uptake, metabolism, and recycling
Andersen, J. V., Schousboe, A., & Wellendorph, P. (2023) · Essays in Biochemistry · doi:10.1042/ebc20220208 · Cited by 61
Self-citationA conserved leucine occupies the empty substrate site of LeuT in the Na+-free return state
Malinauskaitė, L., Said, S., Sahin, C., Grouleff, J., Shahsavar, A., Bjerregaard, H., Noer, P. R., Severinsen, K., Boesen, T. P., Schiøtt, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms11673 · Cited by 60
Self-citationEnhancing GAT-3 in thalamic astrocytes promotes resilience to brain injury in rodents
Cho, F. S., Vainchtein, I. D., Voskobiynyk, Y., Morningstar, A. R., Aparicio, F., Higashikubo, B. T., Ciesielska, A., Broekaart, D. W. M., Anink, J. J., van Vliet, E. A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj4310 · Cited by 58
Transport and inhibition mechanisms of the human noradrenaline transporter
Hu, T., Yu, Z., Zhao, J., Meng, Y., Salomon, K., Bai, Q., Wei, Y., Zhang, J., Xu, S., Dai, Q., et al. (2024) · Nature · doi:10.1038/s41586-024-07638-z · Cited by 57
Glutamate‐101 is critical for the function of the sodium and chloride‐coupled GABA transporter GAT‐1
Keshet, G. I., Bendahan, A., Su, H., Mager, S., Lester, H. A., & Kanner, B. I. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00859-8 · Cited by 52
Molecular basis of human noradrenaline transporter reuptake and inhibition
Tan, J., Xiao, Y., Kong, F., Zhang, X., Xu, H., Zhu, A., Liu, Y., Lei, J., Tian, B., Yuan, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-07719-z · Cited by 51
Cryo-EM structure of GABA transporter 1 reveals substrate recognition and transport mechanism
Nayak, S. R., Joseph, D., Höfner, G. C., Dakua, A., Athreya, A., Wanner, K. T., Kanner, B. I., & Penmatsa, A. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01011-w · Cited by 49
Pabel, J., Faust, M. R., Prehn, C. P., Wörlein, B., Allmendinger, L., Höfner, G. C., & Wanner, K. T. (2012) · ChemMedChem · doi:10.1002/cmdc.201200126 · Cited by 46
Gotfryd, K., Boesen, T., Mortensen, J. S., Khelashvili, G., Quick, M., Terry, D. S., Missel, J., LeVine, M. V., Gourdon, P., Blanchard, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14735-w · Cited by 45
Self-citationKvist, T., Christiansen, B. C., Jensen, A. A., & Bräuner‐Osborne, H. (2009) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620709787581684 · Cited by 44
Kickinger, S., Hellsberg, E., Frølund, B., Schousboe, A., Ecker, G. F., & Wellendorph, P. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.021 · Cited by 39
Self-citationBen-Yona, A., Bendahan, A., & Kanner, B. I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149732 · Cited by 36
Kragholm, B., Kvist, T., Madsen, K. K., Jørgensen, L. M., Vogensen, S. B., Schousboe, A., Clausen, R. P., Jensen, A. A., & Bräuner‐Osborne, H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.007 · Cited by 33
Lie, M. E. K., Gowing, E. K., Johansen, N. B., Dalby, N. O., Thiesen, L., Wellendorph, P., & Clarkson, A. N. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17744123 · Cited by 32
Self-citationGlial GABA Transporters as Modulators of Inhibitory Signalling in Epilepsy and Stroke
Lie, M. E. K., Al-Khawaja, A., Damgaard, M., Haugaard, A. S., Schousboe, A., Clarkson, A. N., & Wellendorph, P. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-55769-4_7 · Cited by 31
Self-citationFocht, D., Neumann, C., Lyons, J. A., Eguskiza, A., Blunck, R., Malinauskaitė, L., Schwarz, I., Javitch, J. A., Quick, M., & Nissen, P. (2020) · The EMBO Journal · doi:10.15252/embj.2020105164 · Cited by 28
Dayan, O., Nagarajan, A., Shah, R., Ben-Yona, A., Forrest, L. R., & Kanner, B. I. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775189 · Cited by 21
Synthesis of N-substituted acyclic β-amino acids and their investigation as GABA uptake inhibitors
Sitka, I., Allmendinger, L., Fülep, G., Höfner, G. C., & Wanner, K. T. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.063 · Cited by 20
Jolidon, S., Alberati, D., Dowle, A., Fischer, H., Hainzl, D., Narquizian, R., Norcross, R. D., & Pinard, E. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.005 · Cited by 18
Ben-Yona, A., & Kanner, B. I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323634 · Cited by 16
Pedersen, C. N., Yang, F., Ita, S., Xu, Y., Akunuri, R., Trampari, S., Neumann, C., Desdorf, L. M., Schiøtt, B., Salvino, J. M., et al. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16179 · Cited by 15
Self-citationAndersen, J. V., Marian, O. C., Qvist, F. L., Westi, E. W., Aldana, B. I., Schousboe, A., Don, A. S., Skotte, N. H., & Wellendorph, P. (2024) · Glia · doi:10.1002/glia.24585 · Cited by 13
Self-citationTóth, K., Höfner, G. C., & Wanner, K. T. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.05.049 · Cited by 13
Lie, M. E. K., Gowing, E. K., Clausen, R. P., Wellendorph, P., & Clarkson, A. N. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17743669 · Cited by 12
Self-citationGABA transport cycle: beyond a GAT feeling
Shahsavar, A., & Wellendorph, P. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01032-5 · Cited by 4
Self-citationBavo, F., Kickinger, S., Lie, M. E. K., Avgerinos, C., Xu, Y., Wilhelmsen, K. S., Wellendorph, P., & Frølund, B. (2023) · Medicinal Chemistry Research · doi:10.1007/s00044-023-03126-7 · Cited by 3
Self-citation
Research works printed but not linked: 3
- Zhu, A. H. , Junhao; Kong, Fang ; Tan, Jiaxin ; Lei, Jianlin ; Yuan, Yafei ; Yan, Chuangye . Molecular basis for substrate recognition and transport of human GABA transporter GAT1. Nature Structural & Molecular Biology (2023). · DOI
- 10.15252/embj.2020105164 · DOI
- 2019, Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix, Acta Cryst, D75, 861
Metadata
- Authors
- Mortensen, J. S., Bavo, F., Smiszek Pedersen, A. P., Storm, J. P., Pape, T., Frølund, B., Wellendorph, P., & Shahsavar, A.
- Affiliations
- University of Copenhagen (DK)
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- Corresponding author
- Wellendorph, Petrine
- Shahsavar, Azadeh
- ORCID
- Venue
- Nature Communications
- Publisher
- openRxiv
- Published
- 2025-03-28
- Volume
- 17
- Issue
- 1
- Pages
- 1774-1774
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC12916826
- OpenAlex
- W7126066672
- Cited by
- 4
- References
- 67
- Citations by year
- 2026: 3 · 2025: 1
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Lundbeckfonden (R368-2021-522)
- Novo Nordisk
- Novo Nordisk Fonden (NFF20OC0065017, NNF24SA0098829, NNF21OC0067835)
- H. Lundbeck A/S
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- GAT-3, GABA transporters, GABAergic neurotransmission, transporter inhibition, inhibitor selectivity, cryo-EM structure, GABA binding, substrate recognition, cation-π interactions, inward-open conformation, epilepsy, rational drug design
- MeSH terms
- gamma-Aminobutyric Acid, Humans, Models, Molecular, Nipecotic Acids, Protein Binding, Protein Conformation, Cryoelectron Microscopy, GABA Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.